Ratings by BTIG (Kambiz Yazdi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/1/2026 | Kazia Therapeutics | KZIA | New Coverage | Buy (N/A) |
14.08 (13.59) |
-3.48% | Details | |
| 6/9/2026 | Zevra Therapeutics, Inc. | ZVRA | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2026 | Absci Corp. | ABSI | New Coverage | Buy (N/A) |
5.16 (10.21) |
97.87% | Details | |
| 4/14/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | vTv Therapeutics | VTVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Zevra Therapeutics, Inc. | ZVRA | New Coverage | Buy (N/A) |
9.98 (13.18) |
32.06% | Details | |
| 3/11/2026 | vTv Therapeutics | VTVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2025 | Sionna Therapeutics | SION | New Coverage | Buy (N/A) |
39.93 (43.95) |
10.07% | Details | |
| 11/19/2025 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
25.11 (40.59) |
61.65% | Details | |
| 11/19/2025 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
197.58 (314.56) |
59.21% | Details | |
| 11/19/2025 | vTv Therapeutics | VTVT | New Coverage | Buy (N/A) |
30.15 (31.58) |
4.74% | Details |
